Derfor bør der udvises forsigtighed, når potente noradrenalin- uptake - hæmmere som f. eks. desipramin, maprotilin eller venlafaxin administreres til parkinsonpatienter i behandling med Tasmar og levodopapræparater.
Therefore, caution should be exercised when potent noradrenaline uptake inhibitors such as desipramine, maprotiline, or venlafaxine are administered to Parkinson’ s disease patients being treated with Tasmar and levodopa preparations.